DECEMBER 15, 2020
Facible Awarded National Institutes of Health Grant to Advance Rapid Test for SARS-CoV-2 (COVID-19)
Facible Biodiagnostics, a purpose-driven startup company focused on creating fast, accurate and affordable hospital-grade biodiagnostic tests, today announced a $250,000 award from The National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx) Tech initiative.
Stay Connected.
